Unaudited Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Sales, net	$ 22,556	$ 17,259
Cost of sales	9,038	6,727
Gross profit	13,518	10,532
Operating expenses:
Sales and marketing	7,874	8,237
Research and development	1,193	1,078
General and administrative	6,419	8,949
Total operating expenses	15,486	18,264
Operating loss	(1,968)	(7,732)
Nonoperating income (expenses):
Interest income (expense), net	66	(8)
Net loss	$ (1,902)	$ (7,740)
Basic loss per common share attributable to ChromaDex Corporation (in dollars per share)	$ (0.03)	$ (0.11)
Diluted loss per common share attributable to ChromaDex Corporation (in dollars per share)	$ (0.03)	$ (0.11)
Basic weighted average common shares outstanding (in shares)	74,796	68,314
Diluted weighted average common shares outstanding (in shares)	74,796	68,314